Report Detail
Global Biosuperior Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4742250 |
- 28 September, 2026 |
- Global |
- 89 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Biosuperior market size was valued at US$ 1098 million in 2025 and is forecast to a readjusted size of US$ 1981 million by 2032 with a CAGR of 8.9% during review period.
Biobetters, also known as biosuperiors, are recombinant protein drugs from an identical class as a present set of biopharmaceuticals is not similar to the source. It is neither a wholly novel medicine nor a generic version of an old drug. It is a biological product designed to increase clinical efficacy while also improving tolerance and lowering dosing/administration frequency.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
This report is a detailed and comprehensive analysis for global Biosuperior market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Biosuperior market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Biosuperior market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Biosuperior market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Biosuperior market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Biosuperior
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Biosuperior market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include F.Hoffmann-La Roche AG, Merck and Co., Sanofi, SERVIER, Porton Biopharma, Eli Lily and Company, Novo Nordisk, Biogen, CSL Behring GmbH, Teva, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Biosuperior market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
G-CSF Biobetters
Insulin Biobetters
Erythropoietin Biobetters
Monoclonal Antibodies Biobetters
Others
Market segment by Application
Cancer
Diabetes
Genetic Disease
Neurological Disorders
Others
Major players covered
F.Hoffmann-La Roche AG
Merck and Co.
Sanofi
SERVIER
Porton Biopharma
Eli Lily and Company
Novo Nordisk
Biogen
CSL Behring GmbH
Teva
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Biosuperior product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Biosuperior, with price, sales quantity, revenue, and global market share of Biosuperior from 2021 to 2026.
Chapter 3, the Biosuperior competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biosuperior breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Biosuperior market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Biosuperior.
Chapter 14 and 15, to describe Biosuperior sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Biosuperior Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 G-CSF Biobetters
- 1.3.3 Insulin Biobetters
- 1.3.4 Erythropoietin Biobetters
- 1.3.5 Monoclonal Antibodies Biobetters
- 1.3.6 Others
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Biosuperior Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Cancer
- 1.4.3 Diabetes
- 1.4.4 Genetic Disease
- 1.4.5 Neurological Disorders
- 1.4.6 Others
- 1.5 Global Biosuperior Market Size & Forecast
- 1.5.1 Global Biosuperior Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Biosuperior Sales Quantity (2021-2032)
- 1.5.3 Global Biosuperior Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 F.Hoffmann-La Roche AG
- 2.1.1 F.Hoffmann-La Roche AG Details
- 2.1.2 F.Hoffmann-La Roche AG Major Business
- 2.1.3 F.Hoffmann-La Roche AG Biosuperior Product and Services
- 2.1.4 F.Hoffmann-La Roche AG Biosuperior Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 F.Hoffmann-La Roche AG Recent Developments/Updates
- 2.2 Merck and Co.
- 2.2.1 Merck and Co. Details
- 2.2.2 Merck and Co. Major Business
- 2.2.3 Merck and Co. Biosuperior Product and Services
- 2.2.4 Merck and Co. Biosuperior Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Merck and Co. Recent Developments/Updates
- 2.3 Sanofi
- 2.3.1 Sanofi Details
- 2.3.2 Sanofi Major Business
- 2.3.3 Sanofi Biosuperior Product and Services
- 2.3.4 Sanofi Biosuperior Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Sanofi Recent Developments/Updates
- 2.4 SERVIER
- 2.4.1 SERVIER Details
- 2.4.2 SERVIER Major Business
- 2.4.3 SERVIER Biosuperior Product and Services
- 2.4.4 SERVIER Biosuperior Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 SERVIER Recent Developments/Updates
- 2.5 Porton Biopharma
- 2.5.1 Porton Biopharma Details
- 2.5.2 Porton Biopharma Major Business
- 2.5.3 Porton Biopharma Biosuperior Product and Services
- 2.5.4 Porton Biopharma Biosuperior Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Porton Biopharma Recent Developments/Updates
- 2.6 Eli Lily and Company
- 2.6.1 Eli Lily and Company Details
- 2.6.2 Eli Lily and Company Major Business
- 2.6.3 Eli Lily and Company Biosuperior Product and Services
- 2.6.4 Eli Lily and Company Biosuperior Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Eli Lily and Company Recent Developments/Updates
- 2.7 Novo Nordisk
- 2.7.1 Novo Nordisk Details
- 2.7.2 Novo Nordisk Major Business
- 2.7.3 Novo Nordisk Biosuperior Product and Services
- 2.7.4 Novo Nordisk Biosuperior Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Novo Nordisk Recent Developments/Updates
- 2.8 Biogen
- 2.8.1 Biogen Details
- 2.8.2 Biogen Major Business
- 2.8.3 Biogen Biosuperior Product and Services
- 2.8.4 Biogen Biosuperior Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Biogen Recent Developments/Updates
- 2.9 CSL Behring GmbH
- 2.9.1 CSL Behring GmbH Details
- 2.9.2 CSL Behring GmbH Major Business
- 2.9.3 CSL Behring GmbH Biosuperior Product and Services
- 2.9.4 CSL Behring GmbH Biosuperior Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 CSL Behring GmbH Recent Developments/Updates
- 2.10 Teva
- 2.10.1 Teva Details
- 2.10.2 Teva Major Business
- 2.10.3 Teva Biosuperior Product and Services
- 2.10.4 Teva Biosuperior Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 Teva Recent Developments/Updates
3 Competitive Environment: Biosuperior by Manufacturer
- 3.1 Global Biosuperior Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Biosuperior Revenue by Manufacturer (2021-2026)
- 3.3 Global Biosuperior Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Biosuperior by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Biosuperior Manufacturer Market Share in 2025
- 3.4.3 Top 6 Biosuperior Manufacturer Market Share in 2025
- 3.5 Biosuperior Market: Overall Company Footprint Analysis
- 3.5.1 Biosuperior Market: Region Footprint
- 3.5.2 Biosuperior Market: Company Product Type Footprint
- 3.5.3 Biosuperior Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Biosuperior Market Size by Region
- 4.1.1 Global Biosuperior Sales Quantity by Region (2021-2032)
- 4.1.2 Global Biosuperior Consumption Value by Region (2021-2032)
- 4.1.3 Global Biosuperior Average Price by Region (2021-2032)
- 4.2 North America Biosuperior Consumption Value (2021-2032)
- 4.3 Europe Biosuperior Consumption Value (2021-2032)
- 4.4 Asia-Pacific Biosuperior Consumption Value (2021-2032)
- 4.5 South America Biosuperior Consumption Value (2021-2032)
- 4.6 Middle East & Africa Biosuperior Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Biosuperior Sales Quantity by Type (2021-2032)
- 5.2 Global Biosuperior Consumption Value by Type (2021-2032)
- 5.3 Global Biosuperior Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Biosuperior Sales Quantity by Application (2021-2032)
- 6.2 Global Biosuperior Consumption Value by Application (2021-2032)
- 6.3 Global Biosuperior Average Price by Application (2021-2032)
7 North America
- 7.1 North America Biosuperior Sales Quantity by Type (2021-2032)
- 7.2 North America Biosuperior Sales Quantity by Application (2021-2032)
- 7.3 North America Biosuperior Market Size by Country
- 7.3.1 North America Biosuperior Sales Quantity by Country (2021-2032)
- 7.3.2 North America Biosuperior Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Biosuperior Sales Quantity by Type (2021-2032)
- 8.2 Europe Biosuperior Sales Quantity by Application (2021-2032)
- 8.3 Europe Biosuperior Market Size by Country
- 8.3.1 Europe Biosuperior Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Biosuperior Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Biosuperior Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Biosuperior Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Biosuperior Market Size by Region
- 9.3.1 Asia-Pacific Biosuperior Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Biosuperior Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Biosuperior Sales Quantity by Type (2021-2032)
- 10.2 South America Biosuperior Sales Quantity by Application (2021-2032)
- 10.3 South America Biosuperior Market Size by Country
- 10.3.1 South America Biosuperior Sales Quantity by Country (2021-2032)
- 10.3.2 South America Biosuperior Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Biosuperior Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Biosuperior Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Biosuperior Market Size by Country
- 11.3.1 Middle East & Africa Biosuperior Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Biosuperior Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Biosuperior Market Drivers
- 12.2 Biosuperior Market Restraints
- 12.3 Biosuperior Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Biosuperior and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Biosuperior
- 13.3 Biosuperior Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Biosuperior Typical Distributors
- 14.3 Biosuperior Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Biosuperior. Industry analysis & Market Report on Biosuperior is a syndicated market report, published as Global Biosuperior Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Biosuperior market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
